Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-23-028518
Filing Date
2023-02-08
Accepted
2023-02-08 16:58:52
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d429377dsc13ga.htm SC 13G/A 36211
  Complete submission text file 0001193125-23-028518.txt   37375
Mailing Address
Business Address
BLATT LAWRENCE (Filed by) CIK: 0001242110 (see all company filings)

Type: SC 13G/A

Mailing Address ONE CORPORATE DR., 2ND FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address ONE CORPORATE DR., 2ND FLOOR SOUTH SAN FRANCISCO CA 94080 (800) 466-6059
Aligos Therapeutics, Inc. (Subject) CIK: 0001799448 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91770 | Film No.: 23599866
SIC: 2836 Biological Products, (No Diagnostic Substances)